Perosphere, Inc. Report issue

For profit Phase 1 Phase 2
Founded: Danbury CT United States (2011)
Status: Acquired by AMAG Pharmaceuticals, Inc. (2018) → now Advanz Pharma (2015)

Organization Overview

First Clinical Trial
2013
NCT01826266
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Perosphere, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

ciraparantag (7 trials)

Drugs in Phase 1 Trials (1)

insulin lispro (humalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 2